Trial Profile
A phase I biocomparison trial of citrate and phosphate salt formulations of SCY 078
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Mar 2016
Price :
$35
*
At a glance
- Drugs Ibrexafungerp (Primary)
- Indications Aspergillosis; Candidiasis; Mycoses
- Focus Pharmacokinetics
- 14 Mar 2016 New trial record